Voluntary announcement regarding Brimstone’s disposal of a majority of its investment in the Scientific Group (Propr BRIMSTONE INVESTMENT CORPORATION LIMITED (Incorporated in the Republic of South Africa) (Registration number 1995/010442/06) Share Code: BRT ISIN Number: ZAE000015277 Share Code: BRN ISIN Number: ZAE000015285 ("Brimstone" or “the Company”) VOLUNTARY ANNOUNCEMENT REGARDING BRIMSTONE’S DISPOSAL OF A MAJORITY OF ITS INVESTMENT IN THE SCIENTIFIC GROUP (PROPRIETARY) LIMITED (“SG”) Brimstone currently holds 25.1% of SG as part of a consortium including Capitalworks Private Equity Partnership, the trustees of the Scientific Management Trust, the trustees of the Scientific Incentive Trust and the Scientific Investment Partnership (collectively “the Consortium”). The Consortium has entered into an agreement with Ascendis Health Limited (“Ascendis”) for the disposal of 100% of the diagnostics business of SG (“SG Diagnostics”), being the majority of the business of SG, to Ascendis (“the Disposal”). The Consortium will retain the medical business of SG. Brimstone shareholders are referred to the announcement released by Ascendis on SENS today setting out the full details of the Disposal. The Disposal will be effective on the first day of the calendar month following fulfilment of the conditions precedent. The consideration payable to the Consortium for the Disposal is as follows: - an amount of R283 733 383 payable in cash in tranches over a period of time to December 2015; and - a maximum amount of R100 000 000 payable in cash only to the extent a pending specified contract is awarded to SG Diagnostics in 2015. It should be noted that the value of the Disposal for Brimstone is less than 5% of Brimstone’s market capitalisation and accordingly this announcement is made voluntarily. Cape Town 27 October 2014 Investment bank and sponsor Nedbank Capital Date: 27/10/2014 03:37:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.